Analgesic nephropathy natural history, complications and prognosis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
<br /> | <br /> | ||
==Overview== | ==Overview== | ||
The prognosis of analgesic nephropathy depends on the scarring and damage to the renal tissue. Most patients in early stages recover to normal [[renal function]] after stopping the [[analgesic]] drug, however some may progress to [[End stage renal disease|end stage renal disease (ESRD)]]. Complications of analgesic nephropathy include: [[Urinary tract infection|urinary tract infections]], varying degrees of [[Renal insufficiency|renal failure]] and [[End stage renal disease|End stage renal disease (ESRD)]]. | |||
==Natural History== | ==Natural History== | ||
* [[Renal function]] in most patients recovers to normal level after stopping the usage of [[analgesic]] drug if it is in the early stages of the disease.<ref name="pmid31082145" /> | |||
* Depending on the scarring and damage to the renal tissue, some patients may progress to [[End stage renal disease|end stage renal disease (ESRD)]], even after stopping the usage of [[analgesic]] drug.<ref name="pmid31082145" /> | |||
==Complications== | ==Complications== | ||
<s>Complications of analgesic nephropathy include [[pyelonephritis]]<ref name="pmid10620560">{{cite journal |author=Maisonneuve P, Agodoa L, Gellert R, ''et al'' |title=Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study |journal=Am. J. Kidney Dis. |volume=35 |issue=1 |pages=157–65 |year=2000 |month=January |pmid=10620560 |doi= |url=http://linkinghub.elsevier.com/retrieve/pii/S0272638600765127}}</ref> and [[end-stage kidney disease]]. Risk factors for poor prognosis include recurrent urinary tract infection and persistently elevated blood pressure. Analgesic nephropathy also appears to increase the risk of developing cancers of the [[urinary system]].<ref name="pmid7045494">{{cite journal |author=Blohmé I, Johansson S |title=Renal pelvic neoplasms and atypical urothelium in patients with end-stage analgesic nephropathy |journal=Kidney Int. |volume=20 |issue=5 |pages=671–5 |year=1981 |month=November |pmid=7045494 |doi= |url=}}</ref></s> | <s>Complications of analgesic nephropathy include [[pyelonephritis]]<ref name="pmid10620560">{{cite journal |author=Maisonneuve P, Agodoa L, Gellert R, ''et al'' |title=Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study |journal=Am. J. Kidney Dis. |volume=35 |issue=1 |pages=157–65 |year=2000 |month=January |pmid=10620560 |doi= |url=http://linkinghub.elsevier.com/retrieve/pii/S0272638600765127}}</ref> and [[end-stage kidney disease]]. Risk factors for poor prognosis include recurrent urinary tract infection and persistently elevated blood pressure. Analgesic nephropathy also appears to increase the risk of developing cancers of the [[urinary system]].<ref name="pmid7045494">{{cite journal |author=Blohmé I, Johansson S |title=Renal pelvic neoplasms and atypical urothelium in patients with end-stage analgesic nephropathy |journal=Kidney Int. |volume=20 |issue=5 |pages=671–5 |year=1981 |month=November |pmid=7045494 |doi= |url=}}</ref></s> | ||
| Line 16: | Line 22: | ||
* [[Transitional cell carcinoma|Transitional cell tumours]] of the [[urothelium]] (in abuse of [[Analgesic|analgesics]] containing [[phenacetin]]) | * [[Transitional cell carcinoma|Transitional cell tumours]] of the [[urothelium]] (in abuse of [[Analgesic|analgesics]] containing [[phenacetin]]) | ||
==Prognosis== | ==Prognosis== | ||
The prognosis of analgesic nephropathy depends on the scarring and damage to the renal tissue. Most patients in early stages recover to normal [[renal function]] after stopping the [[analgesic]] drug, however some may progress to [[End stage renal disease|end stage renal disease (ESRD)]].<ref name="pmid31082145" /> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 13:24, 6 July 2020
|
Analgesic nephropathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Analgesic nephropathy natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Analgesic nephropathy natural history, complications and prognosis |
|
FDA on Analgesic nephropathy natural history, complications and prognosis |
|
CDC on Analgesic nephropathy natural history, complications and prognosis |
|
Analgesic nephropathy natural history, complications and prognosis in the news |
|
Blogs on Analgesic nephropathy natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The prognosis of analgesic nephropathy depends on the scarring and damage to the renal tissue. Most patients in early stages recover to normal renal function after stopping the analgesic drug, however some may progress to end stage renal disease (ESRD). Complications of analgesic nephropathy include: urinary tract infections, varying degrees of renal failure and End stage renal disease (ESRD).
Natural History
- Renal function in most patients recovers to normal level after stopping the usage of analgesic drug if it is in the early stages of the disease.[1]
- Depending on the scarring and damage to the renal tissue, some patients may progress to end stage renal disease (ESRD), even after stopping the usage of analgesic drug.[1]
Complications
Complications of analgesic nephropathy include pyelonephritis[2] and end-stage kidney disease. Risk factors for poor prognosis include recurrent urinary tract infection and persistently elevated blood pressure. Analgesic nephropathy also appears to increase the risk of developing cancers of the urinary system.[3]
Complications associated with analgesic nephropathy include:[4][5]
- Urinary tract infections
- Varying degrees of renal failure
- End stage renal disease (ESRD)[1]
- Transitional cell tumours of the urothelium (in abuse of analgesics containing phenacetin)
Prognosis
The prognosis of analgesic nephropathy depends on the scarring and damage to the renal tissue. Most patients in early stages recover to normal renal function after stopping the analgesic drug, however some may progress to end stage renal disease (ESRD).[1]
References
- ↑ 1.0 1.1 1.2 1.3 "StatPearls". 2020. PMID 31082145.
- ↑ Maisonneuve P, Agodoa L, Gellert R; et al. (2000). "Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study". Am. J. Kidney Dis. 35 (1): 157–65. PMID 10620560. Unknown parameter
|month=ignored (help) - ↑ Blohmé I, Johansson S (1981). "Renal pelvic neoplasms and atypical urothelium in patients with end-stage analgesic nephropathy". Kidney Int. 20 (5): 671–5. PMID 7045494. Unknown parameter
|month=ignored (help) - ↑ Nanra RS (1980). "Clinical and pathological aspects of analgesic nephropathy". Br J Clin Pharmacol. 10 Suppl 2: 359S–368S. doi:10.1111/j.1365-2125.1980.tb01824.x. PMC 1430193. PMID 7002190.
- ↑ Nanra RS, Stuart-Taylor J, de Leon AH, White KH (1978). "Analgesic nephropathy: etiology, clinical syndrome, and clinicopathologic correlations in Australia". Kidney Int. 13 (1): 79–92. doi:10.1038/ki.1978.11. PMID 362034.